|Day Low/High||53.35 / 54.25|
|52 Wk Low/High||31.97 / 58.00|
Jim Cramer says we'll need to pay close attention to retailers' earnings. Here's your game plan for next week.
Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more.
- ELEVATE UC Phase 3 global program site initiations
Investors in Arena Pharmaceuticals Inc saw new options begin trading today, for the June 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new June 28th contracts and identified the following put contract of particular interest.
SAN DIEGO, May 13, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members of its senior management team will participate at the upcoming investor conferences: UBS Global Healthcare Conference on Monday, May 20, at...
- Etrasimod ELEVATE UC Phase 3 Program expected to initiate mid-year targeting significant unmet need in ulcerative colitis
SAN DIEGO, May 1, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2019 financial results and provide a corporate update on Wednesday, May 8, 2019, after the close of the U.
SAN DIEGO, April 3, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARNA, CNTY, GPOR Downgrades: FRPT, JW.A, JW.B, NL, WSR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
SAN DIEGO, March 8, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) presented new Phase 2 data from its investigative drug candidates etrasimod, a next-generation, oral, selective sphingosine 1 phosphate (S1P) receptor modulator in...
- Etrasimod demonstrated clinical response and durable, long-term clinical remission and favorable long-term safety and tolerability in an open-label extension trial
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Feb. 20, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Feb. 7, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Jan. 24, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C.
- Etrasimod demonstrated clinical response and durable, long-term clinical remission
SAN DIEGO, Dec. 19, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Dec. 17, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Nov. 26, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Jim Cramer says perception is determining how stocks trade right now -- and there's a lot of negativity.
Jim Cramer take a closer look at BP, Arconic, Fiat Chrysler, Qualcomm, Thermo Fisher, GameStop, Arena Pharmaceuticals and more.
Let's see what the charts suggest for risk points.
Jim Cramer explains his post-election play book: Growth stocks may be the way to go.
Jim Cramer weighs in on Canada Goose, Celgene, BlackRock, Nio, Hospitality Property Trust, Activision Blizzard and more.
Investors in Arena Pharmaceuticals Inc saw new options begin trading this week, for the September 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 86 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
The S&P 500 has shown the same pattern for three consecutive days.
The best way to deal with it is to keep on hunting for individual stocks.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.